Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview

Immunocompromised (IC) persons are at increased risk for herpes zoster (HZ) and its complications, mainly due to impairment of cell-mediated immunity (CMI). The adjuvanted recombinant zoster vaccine (RZV) demonstrated efficacy against HZ in autologous hematopoietic stem cell transplant (auto-HSCT) r...

Descripción completa

Detalles Bibliográficos
Autores principales: Dagnew, Alemnew F., Vink, Peter, Drame, Mamadou, Willer, David O., Salaun, Bruno, Schuind, Anne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827627/
https://www.ncbi.nlm.nih.gov/pubmed/34190658
http://dx.doi.org/10.1080/21645515.2021.1930846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827627/
https://www.ncbi.nlm.nih.gov/pubmed/34190658
http://dx.doi.org/10.1080/21645515.2021.1930846

Ejemplares similares